XML 23 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance at beginning of period at Dec. 31, 2015 $ 2,009,188 $ 42,377 $ (306,835) $ 721,997 $ (365) $ 1,552,014
Balance (in shares) at Dec. 31, 2015   423,769 9,893      
Increase (Decrease) in Stockholders' Equity            
Net income (loss) (417,124)         (417,124)
Issuance of common stock 995,289 $ 5,060   990,229    
Issuance of common stock (in shares)   50,600        
Exercise of stock appreciation rights (198) $ 3   (201)    
Exercise of stock appreciation rights (in shares)   28        
Stock amortization and vesting 16,931 $ 64   16,867    
Stock amortization and vesting (in shares)   646        
Sale of stock held in rabbi trust 544     544    
Stock-based compensation (2,126)     (2,126)    
Cash dividends (36,187)         (36,187)
Other comprehensive income 1,350       1,350  
Balance at end of period at Dec. 31, 2016 2,567,667 $ 47,504 $ (306,835) 1,727,310 985 1,098,703
Balance (in shares) at Dec. 31, 2016   475,043 9,893      
Increase (Decrease) in Stockholders' Equity            
Cumulative impact from accounting change 42,172         42,172
Net income (loss) 100,393         100,393
Exercise of stock appreciation rights 0 $ 14   (14)    
Exercise of stock appreciation rights (in shares)   137        
Stock amortization and vesting 15,160 $ 37   15,123    
Stock amortization and vesting (in shares)   367        
Cash dividends (78,838)         (78,838)
Purchase of treasury stock (123,741)   $ (123,741)      
Purchase of treasury stock (in shares)     5,043      
Other comprehensive income 1,092       1,092  
Balance at end of period at Dec. 31, 2017 2,523,905 $ 47,555 $ (430,576) 1,742,419 2,077 1,162,430
Balance (in shares) at Dec. 31, 2017   475,547 14,936      
Increase (Decrease) in Stockholders' Equity            
Net income (loss) 557,043         557,043
Exercise of stock appreciation rights 0 $ 1   (1)    
Exercise of stock appreciation rights (in shares)   9        
Stock amortization and vesting 20,778 $ 54   20,724    
Stock amortization and vesting (in shares)   539        
Cash dividends (111,369)         (111,369)
Purchase of treasury stock (904,112)   $ (904,112)      
Purchase of treasury stock (in shares)     38,474      
Other comprehensive income 2,360       2,360  
Cumulative impact from accounting change (446)         (446)
Balance at end of period at Dec. 31, 2018 $ 2,088,159 $ 47,610 $ (1,334,688) $ 1,763,142 $ 4,437 $ 1,607,658
Balance (in shares) at Dec. 31, 2018   476,095 53,410